Compounds > gemfibrozil
Page last updated: 2024-10-27

gemfibrozil and Degenerative Diseases, Central Nervous System

gemfibrozil has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghosh, A1
Pahan, K2
Corbett, GT1
Roy, A1

Other Studies

2 other studies available for gemfibrozil and Degenerative Diseases, Central Nervous System

ArticleYear
Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders.
    The Journal of biological chemistry, 2012, Aug-03, Volume: 287, Issue:32

    Topics: Base Sequence; Cells, Cultured; DNA Primers; Gemfibrozil; Humans; Hypolipidemic Agents; Kruppel-Like

2012
Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense.
    Journal of immunology (Baltimore, Md. : 1950), 2012, Jul-15, Volume: 189, Issue:2

    Topics: Animals; Apoptosis Regulatory Proteins; Cells, Cultured; Cerebral Cortex; Gemfibrozil; Humans; Hypol

2012